课题基金 / 基金详情

Program Planning

Program Planning
节目策划
批准号:
8934262
负责人:
TONY R. HUNTER
金额:
$1.73万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-01 至 2018-11-30

项目摘要

项目成果

TONY R. HUNTER的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结(见说明): 项目规划由癌症中心执行委员会进行,该委员会由主任、三名项目负责人和各自的副项目负责人组成。这个小组每年开会几次,讨论战略,并就项目成员和癌症中心新成员的任命做出决定,包括研究所的新教师招聘。执行委员会与主任和癌症中心管理员一起参与作出关于CCSG资源分配的决策。 在过去的四年里,我们还受益于新成立的索尔克研究所癌症中心外部咨询委员会(EAC)在项目规划方面的建议。该委员会每年与主任、行政长官和执行委员会成员以及癌症中心的所有成员举行会议。会议结束后,选管会举行执行会议,并编写一份书面报告,向司长提出具体建议。
英文摘要
PROJECT SUMMARY (See instructions): Program planning is conducted by a Cancer Center Executive Committee, which consists of the Director and the three Program Leaders and the respective Associate Program Leaders. This group meets several times a year to discuss strategy and make decisions about program membership, and appointment of new members to the Cancer Center, including new faculty recruits to the Institute. Together with the Director and the Cancer Center Administrator, the Executive Committee participates in making decisions about CCSG resource allocation. Over the past four years, we have also had the benefit of the advice of the newly established Salk Institute Cancer Center External Advisory Committee (EAC) in program planning. The EAC meets annually with the Director, Administrator and Executive Committee members and as well as all members of the Cancer Center. After the meeting the EAC holds an executive session and assembles a written report that provides specific recommendations to the Director.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Biostatistics Core
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
Histidine phosphorylation as a new target for cancer therapy
海外基金